BACKGROUND AND OBJECTIVE: We aimed to explore to what extent an unselected population of chronic obstructive pulmonary disease (COPD) outpatients would be eligible for inclusion in randomized clinical trials (RCTs). METHODS: Retrospective analysis of the clinical records of outpatient subjects with an ascertained diagnosis of COPD. COPD outpatients were assessed against the following inclusion criteria: 40 < age < 80 years, current or former smokers, forced expiratory volume in the first second (FEV1) <70% predicted, no long-term oxygen therapy, no other concomitant lung diseases and absence of major extrapulmonary comorbidities. The study consisted of 2 phases; in phase 1, the criteria for inclusion in RCTs on COPD were selected, and in ph...
AbstractEvidence-based medicine is a corner stone in treatment decision making and large randomised,...
INTRODUCTION: Chronic obstructive pulmonary disease (COPD) is a progressive disease affecting 3 mill...
This is an Open Access article distributed under the terms of the Creative Commons Attribution Licen...
BACKGROUND AND OBJECTIVE: We aimed to explore to what extent an unselected population of chronic obs...
International audienceBackgroundIn patients with chronic obstructive pulmonary disease, all efforts ...
Management guidelines of chronic obstructive pulmonary disease (COPD) are mainly based on results of...
Randomized clinical trials (RCTs) are performed to provide evidence to support treatment decisions. ...
Introduction: Chronic obstructive pulmonary disease (COPD) is a progressive disease affecting 3 mill...
Acknowledgments The authors wish to acknowledge Derek Skinner with gratitude for his assistance with...
Introduction: Chronic obstructive pulmonary disease (COPD) is a progressive disease affecting 3 mill...
Abstract Randomized clinical trials (RCTs) are performed to provide evidence to suppo...
SummaryBackgroundCOPD is a heterogeneous disease comprising a wide range of clinical phenotypes, dep...
Rationale: Clinical trial eligibility criteria are employed to efficiently determine intervention ef...
Evidence-based medicine is a corner stone in treatment decision making and large randomised, clinica...
BackgroundRecruitment and retention are two significant barriers in research, particularly for histo...
AbstractEvidence-based medicine is a corner stone in treatment decision making and large randomised,...
INTRODUCTION: Chronic obstructive pulmonary disease (COPD) is a progressive disease affecting 3 mill...
This is an Open Access article distributed under the terms of the Creative Commons Attribution Licen...
BACKGROUND AND OBJECTIVE: We aimed to explore to what extent an unselected population of chronic obs...
International audienceBackgroundIn patients with chronic obstructive pulmonary disease, all efforts ...
Management guidelines of chronic obstructive pulmonary disease (COPD) are mainly based on results of...
Randomized clinical trials (RCTs) are performed to provide evidence to support treatment decisions. ...
Introduction: Chronic obstructive pulmonary disease (COPD) is a progressive disease affecting 3 mill...
Acknowledgments The authors wish to acknowledge Derek Skinner with gratitude for his assistance with...
Introduction: Chronic obstructive pulmonary disease (COPD) is a progressive disease affecting 3 mill...
Abstract Randomized clinical trials (RCTs) are performed to provide evidence to suppo...
SummaryBackgroundCOPD is a heterogeneous disease comprising a wide range of clinical phenotypes, dep...
Rationale: Clinical trial eligibility criteria are employed to efficiently determine intervention ef...
Evidence-based medicine is a corner stone in treatment decision making and large randomised, clinica...
BackgroundRecruitment and retention are two significant barriers in research, particularly for histo...
AbstractEvidence-based medicine is a corner stone in treatment decision making and large randomised,...
INTRODUCTION: Chronic obstructive pulmonary disease (COPD) is a progressive disease affecting 3 mill...
This is an Open Access article distributed under the terms of the Creative Commons Attribution Licen...